Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 3 Neoplasms 2 Sarcoidosis 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Pancreatic Diseases 1 Pancreatic Cyst 1 Neuroendocrine Tumors 1 Neoplastic Cells, Circulating 1 Lymphoma, Follicular 1 Lymphoma 1 Lymphadenopathy 1 Lung Neoplasms 1 Lung Cancer Metastatic 1 Disease 1

Interventions

tremelimumab 1 regramostim 1 osimertinib 1 evolocumab 1 durvalumab 1 Surgical Instruments 1 Radiotherapy 1 Radiation 1 Nivolumab 1 Needles 1 MLN 8237 1 Ipilimumab 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Cancer Metastatic × Needles × Clear all

NCT05706883 2024-04-05

ProphetaPro

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡